Publication | Closed Access
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
296
Citations
22
References
2011
Year
PD-0332991 shows promising biologic activity in ovarian cancer cell lines. Assessment of Rb and p16 expression may help select patients most likely to benefit from CDK4/6 inhibition in ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1